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Introduction
!
Colorectal cancer (CRC) is the second most com-
mon cause of cancer death in the United Kingdom
[1]. The majority of CRCs develop from adenomas
[2]. Adenoma detection is therefore a key objec-
tive of colonoscopy. Adenoma detection rate
(ADR) is widely regarded as one of the key per-
formance indicators of colonoscopy [3]. Increas-
ing ADR has been shown to correlate with de-
creased interval cancer rate [4].
Multiple factors may affect whether an adenoma
is detected during colonoscopy. These may be pa-
tient factors such as male sex, increasing age, ci-
garette smoking, and alcohol use [5–9].
This study focused on the colonoscopy factors
(many of which relate to the completeness of pan-
colonic mucosal inspection) that determine
whether adenomas are detected. Cecal intuba-
tion, colonoscopy withdrawal time, and bowel
preparation quality have been shown to be asso-
ciated with increased adenoma detection [10–
16]. Other technical factors, such as intravenous
antispasmodic use, rectal retroversion, start time
of the procedure, and sedation practice, have
been postulated as affecting adenoma detection
with conflicting findings in studies to date [17–
26]. These factors are important as they are mod-
ifiable by the colonoscopist, offering the opportu-
nity to optimize adenoma detection, and may re-
duce future cancer risk.
Intravenous antispasmodics, such as hyoscine N-
butylbromide, relax smooth muscle in the colon,
minimizing haustral definition and theoretically
reducing the amount of mucosa not visible to a
forward-viewing colonoscope. Recent studies
have produced conflicting findings on the effect
of hyoscine on adenoma detection [17–20].
Few previous studies of technical aspects of colo-
noscopy have included the full range of currently
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Background and study aims: Adenoma detection
is a key objective of colonoscopy, particularly in
the context of colorectal cancer screening. The
aim of this observational study was to identify
the technical colonoscopy factors associated with
adenoma detection.
Patients and methods: The study analyzed data
from the English Bowel Cancer Screening Pro-
gramme. The indication for all colonoscopies was
a positive fecal occult blood test. The relationships
between the following colonoscopy factors and
adenoma detection (one or more adenomas, ad-
vanced adenomas, right-sided adenomas, and to-
tal number of adenomas) were examined in mul-
tivariable analyses: bowel preparation quality, ce-
cal intubation, withdrawal time, rectal retrover-
sion, colonoscopist experience, antispasmodic
use, sedation use, and start time of procedure.
The following patient factors were controlled for:
age, sex, body mass index, smoking, alcohol, de-
privation, and geographical location.
Results: A total of 31088 colonoscopies were ana-
lyzed. The following technical factors increased
the relative risk of adenoma detection (P<0.001
in multivariable analysis unless otherwise sta-
ted): cecal intubation, increased withdrawal
time, higher quality bowel preparation, intrave-
nous antispasmodic use, earlier procedure start
timewithin a session (P=0.018), and greater colo-
noscopist experience. Detection of advanced and
right-sided adenomas also increased with these
factors. Adenoma detection did not differ be-
tween sedated and unsedated colonoscopy (P=
0.143).
Conclusion: This study demonstrated important
associations between colonoscopy practice and
adenoma detection. Use of intravenous antispas-
modic was associated with increased adenoma
detection. The effect of the start time of colonos-
copy suggests that endoscopist fatiguemay have a
deleterious impact on adenoma detection.
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known, measurable technical variables of colonoscopy in addi-
tion to patient factors, to examine the likelihood of adenomas
being detected. This approach is necessary to allow for confound-
ing between potential risk factors and enables known risk factors
for neoplasia to be controlled for while examining the role of po-
tentially modifiable aspects of colonoscopy practice.
The English Bowel Cancer Screening Programme (BCSP) was cho-
sen as the setting for this study as it provides a population under-
going colonoscopy for a consistent indication (positive fecal oc-
cult blood test) with a prospectively collected comprehensive da-
taset [27]. In addition, quality assurance processes are built in to
the BCSP to ensure that detailed data on patients and procedures
are prospectively collected, and colonoscopists practising in the
program are required to meet stringent selection criteria and
maintain ongoing high standards of performance [28].
The aim of this study was to identify colonoscopy technical fac-
tors associated with increased or decreased risk of adenoma de-
tection.
Patients and methods
!
Study population
The English BCSP offers biennial nonrehydrated guaiac-based fe-
cal occult blood test (FOBT) to individuals in England aged 60–69
years (the upper age limit was extended to 74 in 2010). Individ-
uals with a positive FOBT are offered colonoscopy [29]. Prior to
commencing practice in the BCSP, all colonoscopists are required
to undergo a comprehensive accreditation process. Accredited
colonoscopists are then subject to ongoing audit of colonoscopic
performance [28].
All colonoscopies in the BCSP between August 2006 and August
2009 were studied. The indication for all procedures was a posi-
tive FOBT. Surveillance colonoscopies were excluded from analy-
sis, and in cases where an individual had more than one proce-
dure in a screening episode, only the first procedure was includ-
ed in order to avoid double-counting of adenomas. Demographic,
colonoscopic, and histological data were prospectively collected
and collated centrally in the Bowel Cancer Screening System
(BCSS) database.
Demographic and lifestyle data (date of birth, sex, smoking sta-
tus, alcohol consumption, height in metres, weight in kg, postal
code) were prospectively collected from individuals prior to colo-
noscopy during a pre-colonoscopy assessment with a trained
screening practitioner.
Study procedures
Data downloaded from the BCSS database were checked for com-
pleteness and plausibility. When possible, missing data were re-
trieved from the screening center. Completeness of data was vali-
dated by cross checking with local data sources. Data entries for
continuous variables (height, weight, drug doses, andwithdrawal
time) that were considered implausible by panel decision were
excluded from further analysis. These data cleaning processes
are described in further detail in a previous publication [28].
Colonoscopy data recorded at the time of the procedure included
cecal intubation (as evidenced by anatomical landmarks), with-
drawal time (defined as the time taken to withdraw the colono-
scope from the cecum to the anus), rectal retroversion, sedative
medication or intravenous antispasmodic (hyoscine N-butylbro-
mide) use, and quality of bowel preparation. Bowel preparation
quality was recorded on a four-point scale. Descriptors for bowel
preparation quality were: incomplete examination due to inade-
quate preparation; complete examination despite inadequate
preparation; adequate or excellent preparation [30].
Mean colonoscopy withdrawal timeswere calculated for each co-
lonoscopist for negative complete procedures only (nc-CWT). Use
of actual withdrawal times for individual procedures is not ap-
propriate as it is influenced by the duration of therapeutic proce-
dures rather than time spent examining the colonic mucosa dur-
ing withdrawal [13]. Mean nc-CWT per colonoscopist were fur-
ther dichotomized into two groups (<10 minutes, ≥10 minutes)
based on a previous study suggesting that colonoscopists with
mean nc-CWT≥10 minutes tended to have higher ADR than
those with shorter mean withdrawal times [13]. A cut-off time
of 6 minutes was not used in this analysis as only 15% of colonos-
copists had a mean withdrawal time below this threshold and no
clinically significant relationship between ADR and mean nc-
CWTwere observed with this cut-off in univariable analysis. Ex-
ploratory analysis with nc-CWT as a continuous variable did not
affect the findings.
Exploratory analysis of start time of procedure suggested a rela-
tionship between how early in the morning or afternoon session
the procedure was commenced and adenoma detection. Proce-
dure start time was therefore divided into two groups. In one
group, the procedure commenced in the first half of a session
(08:00–11:00 or 14:00–16:00); the second group consisted of
procedures starting in the second half of the session (11:00–
14:00 or 16:00–18:00).
All colonoscopists in the BCSP had completed at least 1000 proce-
dures during their career prior to obtaining accreditation to com-
mence screening colonoscopy. To account for colonoscopist ex-
perience of colonoscopy in the screening program, procedures
were grouped into those among the first 300 procedures per-
formed by an individual colonoscopist in the screening program
and subsequent procedures. The cut-off at 300 procedures per co-
lonoscopist was determined by exploratory analysis, which
showed no significant relationship when groups of 100 or 200
procedures were used.
Finally, procedures were assigned to a group depending on
whether intravenous sedative/analgesic medication was used or
the procedure was performed unsedated. The use of sedative
medication or intravenous antispasmodic medication was at the
discretion of the colonoscopist and patient.
Patient age was recorded on the date of colonoscopy. Age was
analyzed as a categorical variable (<62.5, 62.5–64.9, 65.0–
67.49,≥67.5 years) to aid interpretation of results. Smoking sta-
tus was categorized as current smoker, ex-smoker or never
smoked. Alcohol use was dichotomized as either current use or
not. Body mass index (BMI, kg/m2) was calculated from self-re-
ported height and weight measurements and grouped into two
categories (<25.0 and≥25.0kg/m2). Deprivation scores (a meas-
ure of the socioeconomic status of the individual) were assigned
using an individual’s postal code at the time of entry to the
screening program. Postal codes were linked to the Index of Mul-
tiple Deprivation scores (IMD) at the Lower Super Output Area
level. In subsequent analysis the IMD scores of the study popula-
tion were ranked in quintiles from highest to lowest deprivation
scores, where group 1 was the most deprived and group 5 the
least deprived [31].
The BCSP is coordinated by five hubs, which are responsible for
inviting individuals for the FOBT. The hub inwhich the individual
lived at the time of invitation to the screening program was in-
cluded in the study as a geographical variable.
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The number, location, size, and histological grade of each adeno-
ma detected during colonoscopy were recorded. This allowed co-
lonoscopies to be classified according to the following outcomes:
one or more adenomas detected, one or more advanced adeno-
mas detected (defined as adenomas≥1cm in size or displaying
high grade dysplasia or polyp cancer), one or more right-sided
adenomas (lesions at or proximal to the splenic flexure), and
one or more rectal adenomas detected. Only lesions that were
histologically confirmed as adenomas were counted; these in-
cluded, tubular, tubulovillous, villous, and serrated adenomas. In
addition, the total number of adenomas detected at each proce-
dure was recorded.
Approval of this study as service evaluation was obtained from a
Regional Ethics Committee.
Statistical analysis
Normally distributed continuous variables are presented as
mean (±SD). Categorical variables are presented as total propor-
tions and percentages (n, %). Univariable analysis was performed
using the chi-squared test for comparison of categorical variables
and the unpaired t test for continuous variables. This exploratory
testing identified variables that were associated with the pres-
ence of one or more adenomas. The procedure was repeated to
identify variables associated with the presence of one or more
advanced adenomas, right-sided adenomas, and rectal adeno-
mas. In order to allow for confounding between variables, multi-
variable analysis using binary logistic regression to calculate
odds ratios (OR) with 95% confidence intervals (CI) was per-
formed. Four separate models (with ≥1 adenoma, ≥1 advanced
adenoma, ≥1 right-sided adenoma, and≥1 rectal adenoma as
the dependent variables) were analyzed using the forward step-
wise logistic regression approach.
The following patient variables were tested: sex, age, smoking
status, alcohol use, BMI category, deprivation quintile, hub area.
The following colonoscopy variables were tested: cecal intuba-
tion, rectal retroversion, colonoscopist mean nc-CWT group,
bowel preparation quality, hyoscine use, procedure start time
group, colonoscopist experience group, and intravenous sedation
group.Variables were included in the multivariable models if
they reached a significance level of P≤0.1 in univariable testing.
Table 1 Univariable analysis demonstrating relationships between patient characteristics and proportions of patients with one or more adenomas, advanced
adenomas, and right-sided adenomas.
Patient characteristics Patients (n=31
088), n (%)
Patients with ≥1
adenoma (n=
14423), n (%)1
P Patients with ≥1
advanced adeno-
ma (n=8985),
n (%)1
P Patients with ≥1
right-sided ade-
noma (n=5999),
n (%)1
P
Sex
Female 12 327 (39.7) 4505 (36.5) < 0.001 2737 (22.2) < 0.001 1614 (13.1) < 0.001
Male 18 761 (60.3) 9918 (52.9) 6248 (33.3) 4385 (23.4)
Age, years
< 62.5 8415 (27.1) 3644 (43.3) < 0.001 2273 (27.0) < 0.001 1418 (16.9) < 0.001
62.5–64.9 4959 (16.0) 2235 (45.1) 1351 (27.2) 954 (19.2)
65–67.49 6844 (22.0) 3181 (46.5) 2009 (29.4) 1322 (19.3)
≥67.5 10 870 (35.0) 5363 (49.3) 3352 (30.8) 2305 (21.2)
Smoking2
Never 17 039 (54.8) 7280 (42.7) < 0.001 4481 (26.3) < 0.001 2937 (17.2) < 0.001
Ex-smoker 10 344 (33.3) 5145 (49.7) 3323 (32.1) 2138 (20.7)
Current smoker 3517 (11.3) 1923 (54.7) 1136 (32.3) 891 (25.3)
Alcohol3
No 10422 (33.5) 4069 (39.0) < 0.001 2363 (22.7) < 0.001 1596 (15.3) < 0.001
Yes 20 364 (65.5) 10233 (50.3) 6547 (32.1) 4349 (21.4)
BMI4, kg/m2
< 25.0 6588 (21.2) 3020 (45.8) 0.179 1869 (28.4) 0.226 1249 (19.0) 0.376
≥25.0 19 413 (62.4) 9085 (46.8) 5660 (29.2) 3778 (19.5)
Deprivation Group5
1 (most deprived quintile) 6215 (20.0) 2765 (44.5) < 0.001 1620 (26.1) < 0.001 1201 (19.3) 0.909
2 6216 (20.0) 2837 (45.6) 1703 (27.4) 1226 (19.7)
3 6217 (20.0) 2876 (46.3) 1781 (28.6) 1189 (19.1)
4 6217 (20.0) 2933 (47.2) 1888 (30.4) 1192 (19.2)
5 (least deprived quintile) 6207 (20.0) 3005 (48.4) 1989 (32.0) 1188 (19.1)
Hub area
Midlands 9369 (30.1) 4191 (44.7) < 0.001 2601 (27.8) < 0.001 1726 (18.4) < 0.001
South 5633 (18.1) 2740 (48.6) 1764 (31.3) 1056 (18.7)
London 4636 (14.9) 1966 (42.4) 1107 (23.9) 976 (21.1)
North-East 4864 (15.6) 2375 (48.8) 1540 (31.7) 905 (18.6)
Eastern 6586 (21.2) 3151 (47.8) 1973 (30.0) 1336 (20.3)
BMI, body mass index.
1 Calculated as a percentage of the respective patient characteristics.
2 Smoking status of patient not known for 188 procedures (0.60%).
3 Alcohol usage of patient not known for 302 procedures (0.97%).
4 BMI of patient not known for 5807 procedures (18.7%).
5 Postcode (and deprivation index) of patient not known for 16 procedures (0.05%).
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A similar approach using an ordinal regressionmodelwas used to
examine the relationship between patient and colonoscopy fac-
tors and the total number of adenomas detected. The Pearson
chi-squared test was used to assess goodness of fit of models (a
P value >0.05 suggested the model fits adequately). All reported
P values are two sided, and a P value of less than 0.05 was consid-
ered significant. Analyses were undertaken using SPSS version
17.0 (SPSS Inc., Chicago, Illinois, USA).
Results
!
Patient and procedure characteristics
A total of 31 088 FOBT-positive colonoscopies were analyzed.
These were performed by 148 colonoscopists. A total of 18 761
(60.3%) procedures involved male patients. The mean (±SD) age
of patients was 65.8±3.75 years. One or more adenomas were
detected in 14423 of 31088 procedures (46.4%). One or more ad-
vanced adenomas were detected in 8985 procedures (28.9%).
One or more right-sided adenomas were detected in 5999 proce-
dures (19.2%). The mean number of adenomas detected per pro-
cedure was 0.91±0.25.
Demographic and lifestyle characteristics of the study population
are shown in●" Table1 with univariable analyses for each of the
outcome variables.
●" Table2 shows colonoscopy factors and univariable associations
with each outcome variable. Cecal intubation (unadjusted) was
achieved in 95.6% of procedures and was significantly associated
with increased detection of one or more adenomas, advanced
adenomas, and right-sided adenomas (all P<0.001). Rather than
exclude incomplete procedures from multivariable analysis, this
variable was included in the logistic regression to adjust for cecal
intubation. Rectal retroversion was not associated with detection
of adenomas or right-sided adenomas (P=0.645 and 0.581,
respectively), and was performed in fewer patients with one or
more advanced adenomas (28.5% vs. 32.1%; P<0.001). Further
analysis was performed to examine the effect of rectal retrover-
sion on rectal adenoma detection. In 27973 procedures where
rectal retroversion was performed, one or more rectal adenomas
were detected in 2523 procedures (9.0%). In comparison, one or
more rectal adenomas were detected in 273 of 3115 procedures
in which rectal retroversion was not performed (8.8%; P=0.666).
The relationship between rectal retroversion and rectal adenoma
detection did not change when age and sex were accounted for.
Colonoscopy variables in the multivariable model are shown in
●" Table3. The colonoscopy variables (mean nc-CWT≥10 min-
utes, excellent or adequate bowel preparation, intravenous anti-
spasmodic use, and colonoscopists prior screening experience>
300 procedures) were all associatedwith an increase in adenoma
detection with statistically significant odds ratios between 1.10
(95%CI 1.05–1.16) and 1.38 (95%CI 1.23–1.54). Procedures start-
Table 2 Univariable analysis demonstrating relationships between colonoscopy characteristics and proportions of patients with one or more adenomas, ad-
vanced adenomas, and right-sided adenomas.
Colonoscopy characteristics Patients (n=
31 088), n (%)
Patients with
≥1 adenoma
(n=14 423),
n (%)1
P Patients with
≥1 advanced
adenoma
(n=8985),
n (%)1
P Patients with
≥1 right-sided
adenoma (n=
5999), n (%)1
P
Cecal Intubation
No 1365 (4.4) 244 (17.9) < 0.001 151 (11.1) < 0.001 57 (4.2) < 0.001
Yes 29 723 (95.6) 14179 (47.7) 8834 (29.7) 5942 (20.0)
Rectal retroversion
No 3115 (10.0) 1433 (46.0) 0.645 1001 (32.1) < 0.001 589 (18.9) 0.581
Yes 27 973 (90.0) 12990 (46.4) 7984 (28.5) 5410 (19.3)
Colonoscopist mean nc-CWT,
minutes
< 10 19816 (63.7) 9020 (45.5) < 0.001 5769 (29.1) 0.280 3609 (18.2) < 0.001
≥10 11272 (36.3) 5403 (47.9) 3216 (28.5) 2390 (21.2)
Bowel preparation quality2
Inadequate preparation 1637 (5.3) 620 (37.9) < 0.001 360 (22.0) < 0.001 277 (16.9) 0.011
Excellent or adequate 29 280 (94.2) 13775 (47.0) 8610 (29.4) 5708 (19.5)
Antispasmodic use
No 20521 (66.0) 9129 (44.5) < 0.001 5629 (27.4) < 0.001 3718 (18.1) < 0.001
Yes 10 567 (34.0) 5294 (50.1) 3356 (31.8) 2281 (21.6)
Start time of procedure3
08:00–11:00 or 14:00–16:00 19635 (63.2) 9244 (47.1) 0.010 5810 (29.6) 0.003 3857 (19.6) 0.125
11:00–14:00 or 16:00–18:00 9790 (31.5) 4453 (45.5) 2732 (27.9) 1849 (18.9)
Prior colonoscopist experience in the BCSP (number of procedures)
0–299 27844 (89.6) 12858 (46.2) 0.027 7972 (28.6) 0.002 5290 (19.0) < 0.001
≥300 3244 (10.4) 1565 (48.2) 1013 (31.2) 709 (21.9)
Sedation
Used 27012 (86.9) 12422 (46.0) < 0.001 7750 (28.7) 0.036 5149 (19.1) 0.007
Not used 4076 (13.1) 2001 (49.1) 1235 (30.3) 850 (20.9)
nc-CWT, Mean negative complete colonoscopy withdrawal time; BCSP, Bowel Cancer Screening Programme
1 Calculated as a percentage of the respective colonoscopy characteristics.
2 Bowel preparation quality not known for 171 procedures.
3 Start time not known or not valid for 1663 procedures (5.3%).
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ing in the second half of a session (11:00–14:00 or 16:00–18:00)
were associated with a reduction in detection of adenomas and
advanced adenomas (OR 0.94, 95%CI 0.90–0.99 [P=0.018] and
0.93, 95%CI 0.88–0.98 [P<0.001]) compared with procedures
starting between 08:00 and 11:00 or 14:00 and 16:00.●" Fig.1
demonstrates this relationship along with withdrawal time,
bowel preparation quality, and cecal intubation, which do not
vary throughout the day.
In univariable analysis, procedures inwhich no intravenous seda-
tion was used were associated with lower adenoma, advanced
Table 3 Multivariable logistic regression demonstrating relationships between patient and colonoscopy factors with one or more adenomas, advanced ade-
nomas, and right-sided adenomas as the outcome variables.
Adjusted OR [95%
CI] for≥1 adenomas
P Adjusted OR [95%
CI] for≥1 advanced
adenomas
P Adjusted OR [95%
CI] for≥1 right-sided
adenomas
P
Sex
Female 1.00 1.00 1.00
Male 1.77 [1.68–1.86] < 0.001 1.55 [1.46–1.64] < 0.001 1.88 [1.76–2.01] < 0.001
Age, years
< 62.5 1.00 1.00 1.00
62.5–64.9 1.08 [1.00–1.16] .048 1.03 [0.94–1.11] 0.559 1.20 [1.09–1.32] < 0.001
65–67.49 1.17 [1.09–1.25] < 0.001 1.15 [1.07–1.24] < 0.001 1.22 [1.12–1.33] < 0.001
≥67.5 1.32 [1.24–1.40] < 0.001 1.23 [1.15–1.31] < 0.001 1.41 [1.31–1.52] < 0.001
Smoking
Never 1.00 1.00 1.00
Ex-smoker 1.17 [1.11–1.23] < 0.001 1.17 [1.11–1.24] < 0.001 1.09 [1.02–1.16] < 0.001
Current smoker 1.61 [1.49–1.75] < 0.001 1.34 [1.22–1.45] < 0.001 1.57 [1.44–1.72] < 0.001
Alcohol
No 1.00 1.00 1.00
Yes 1.30 [1.24–1.37] < 0.001 1.38 [1.30–1.46] < 0.001 1.27 (1.18–1.35) < 0.001
Deprivation group –
1 (most deprived quintile) 1.00 1.00 –
2 1.07 [0.99–1.15] 0.102 1.09 [1.00–1.18] 0.056 –
3 1.09 [1.01–1.17] 0.034 1.15 [1.06–1.25] 0.001 –
4 1.10 [1.01–1.19] 0.022 1.22 [1.12–1.33] < 0.001 –
5 (least deprived quintile) 1.15 [1.06–1.24] 0.001 1.32 [1.21–1.44] < 0.001 –
Hub area
Midlands 1.00 1.00 1.00
South 1.21 [1.13–1.31] < 0.001 1.25 [1.15–1.35] < 0.001 1.12 [1.03–1.23] 0.012
London 0.99 [0.92–1.07] 0.517 0.91 [0.83–0.99] 0.026 1.43 [1.30–1.57] < 0.001
North-East 1.26 [1.17–1.34] < 0.001 1.35 [1.25–1.47] < 0.001 1.17 [1.06–1.28] 0.002
Eastern 1.19 [1.11–1.27] < 0.001 1.17 [1.08–1.26] < 0.001 1.26 [1.16–1.37] < 0.001
Cecal Intubation
No 1.00 1.00 1.00
Yes 3.71 [3.12–4.33] < 0.001 3.34 [2.77–4.02] < 0.001 5.55 [4.17–74] <0.001
Rectal retroversion
No - 1.00 –
Yes - 0.64 [0.59–0.70] < 0.001 –
Mean nc-CWT, minutes
< 10 1.00 – 1.00
≥10 1.10 [1.05–1.16] < 0.001 – 1.28 [1.20–1.36] < 0.001
Bowel preparation quality
Inadequate preparation 1.00 1.00 1.00
Excellent or adequate 1.38 [1.23–1.54] < 0.001 1.39 [1.22–1.57] < 0.001 1.16 [1.01–1.33] 0.035
Hyoscine use
No 1.00 1.00 1.00
Yes 1.29 [1.23–1.36] < 0.001 1.29 [1.22–1.36] < 0.001 1.22 [1.15–1.30] < 0.001
Start time of procedure
08:00–11.00 or 14:00–16:00 1.00 1.00 –
11:00–14:00 or 16:00–18:00 0.94 [0.90–0.99] 0.018 0.93 [0.88–0.98] < 0.001 –
Prior colonoscopist experience in the BCSP (number of procedures)
0–299 1.00 1.00 1.00
≥300 1.20 [1.11–1.30] < 0.001 1.23 [1.13–1.24] < 0.001 1.38 [1.22–1.47] < 0.001
IV Sedation
Used 1.00 1.00 1.00
Not used 1.06 [0.98–1.14] 0.143 1.05 [0.97–1.14] 0.210 1.01 [0.93–1.10] 0.866
OR, odds ratio; CI, Confidence interval; nc-CWT, mean negative complete colonoscopy withdrawal time; BCSP, Bowel Cancer Screening Programme.
Variables with a P value<0.1 in univariable analysis were not included.
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adenoma, and right-sided adenoma detection; however, once
other variables were adjusted for in the multivariable models,
no significant difference in outcome was seen between the two
groups.
The Pearson chi-squared goodness of fit test for each of the final
models revealed P values of 0.077, 0.264, and 0.478 for each of
the models, respectively.
The ordinal regression model demonstrating the relationship be-
tween the total number of adenomas detected at each colonosco-
py and patient and colonoscopy factors is shown in●" Table4. The
odds ratio refers to the odds of the group havingmore or less ade-
nomas in total than the reference group.
Discussion
!
This large, national observational study of colonoscopy in a well-
defined population found that intravenous antispasmodic drug
use, cecal intubation, higher quality bowel preparation, mean
withdrawal time of the colonoscopist greater than 10 minutes,
earlier start time of the procedure, and prior colonoscopist ex-
perience were associated with significantly increased adenoma
detection. These factors had similar associations with advanced
adenoma detection, right-sided adenoma detection, and total
number of adenomas detected. Rectal retroversion was not asso-
ciated with an increase in rectal adenoma detection. Cecal intu-
bation was strongly associated with increased adenoma detec-
tion. Several potential explanations exist: lesions proximal to
the point of insertion will have been missed; the cause of the in-
complete examination (e.g. poor preparation or diverticulosis)
may reduce mucosal visualization; in the context of a malignant
stricture the colonoscopist may have reducedmotivation to iden-
tify or report adenomas; finally, if the examination was incom-
plete due to poor bowel preparation, the colonoscopist may not
look for adenomas as they know a repeat procedure will be re-
quired. An alternative approach to this method of analysis would
be to exclude incomplete procedures; doing so resulted in mini-
mal change to the outcome of the models but reduced the size of
the study population.
Adenomas were less likely to be detected in individuals with in-
adequate bowel preparation. This corroborates a recent study de-
monstrating increased missed rates where the bowel preparation
was poor [32]. Improving bowel preparation quality is a widely
accepted method of improving adenoma detection [14–16].
Rectal retroversion was not shown to increase detection of either
adenomas or rectal adenomas. It was associated with a reduction
in detection of advanced adenomas throughout the colon. A po-
tential explanation is that rectal retroversion may be less likely to
be performed if significant pathology has been detected earlier in
the procedure. Although a previous study of 480 screening flex-
ible sigmoidoscopies showed a benefit from rectal retroversion
[21], a more recent study showed that rectal retroversion did
not detect clinically important neoplasia after careful forward-
viewing examination and emphasized the potential harm of the
maneuver [22]. The current study supports the conclusion of this
latter study that following thorough antegrade inspection of the
distal rectum, retroversion should be at the discretion of the co-
lonoscopist.
The current retrospective study appears to support the routine
use of intravenous antispasmodic (hyoscine N-butylbromide):
its use was associated with a 30% higher adenoma detection. Its
use was also associated with higher detection rates of advanced
adenomas, right-sided lesions, and total number of adenomas. It
is not clear whether the administration of the antispasmodic is
directly responsible for the increase in adenoma detection or
whether antispasmodic use is more usual practice of higher per-
forming colonoscopists. Existing literature is conflicting on the
role of antispasmodic use during colonoscopy in terms of proce-
dure time and patient comfort [17–20, 33]. A randomized con-
trolled trial within a population such as the NHS BCSP would be
desirable.
The study identified higher adenoma detection with earlier pro-
cedure start time during both morning and afternoon lists. BCSP
lists are half-day sessions, limited to four colonoscopies, so time
pressure should beminimal. Neither quality of bowel preparation
nor withdrawal time accounted for this effect. One possible ex-
planation is that colonoscopist fatigue may be contributing to re-
duced adenoma detection as the list progresses. It is also possible
that colonoscopists choose to ignore the presence of an adenoma
to avoid delaying the finish of the list, althoughwe feel that this is
unlikely as BCSP colonoscopists are aware that their ADR is under
continuous review. Two American studies have demonstrated
that polyp detection decreases in afternoon compared with
morning colonoscopy and with each subsequent hour of the day
[23, 24]. However, the effect of bowel preparation quality was not
accounted for in either of these studies. A recent single-center
American study of 20 colonoscopists observed a similar phenom-
enon of declining polyp detection toward the end of an endosco-
pist’s shift [24]. Further investigation into the potential role of
operator fatigue during colonoscopy is required.
Pe
rc
en
ta
ge
 o
f c
ol
on
os
co
pi
es
 w
ith
 ≥
1 
ad
en
om
a
W
ith
dr
aw
l t
im
e 
(m
in
ut
es
), 
ce
ca
l i
nt
ub
at
io
n,
 
an
d 
bo
w
el
 p
re
pa
ra
tio
n 
qu
al
ity
 (%
)
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
Start hour of colonoscopy
≥1 adenoma
Mean nc-CWT (minutes)
Cecal intubation (%)
Excellent or adequate bowel 
preparation quality (%)
50
49
48
47
46
45
44
43
42
41
40
100
90
80
70
60
50
40
30
20
10
0
Fig.1 Relationship between start time of colonoscopy and adenoma de-
tection, withdrawal time, cecal intubation, and bowel preparation quality.
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Previous reports on the effect of colonoscopist experience on
adenoma detection are conflicting. A number of studies show no
relationship or a negative association between increasing experi-
ence and adenoma detection [10–13]. A study of adenoma detec-
tion in a large trial of flexible sigmoidoscopy screening demon-
strated that the ADR of some endoscopists increased with experi-
ence [34]. The current data suggest that individuals colonoscoped
by a colonoscopist who had performed ≥300 colonoscopies in the
screening program were 1.2 times more likely to have one or
more adenomas than if the colonoscopist had performed <300
procedures. These data are of note in light of recent European
guidelines that recommend screening colonoscopists perform a
minimum of 300 procedures per year [35].
Unsedated colonoscopy comprised 13.1% of colonoscopies in the
study. Two recent American studies have suggested that deeper
sedation is associated with increased detection of colonic patho-
logy [25,26]. Although depth of sedation was not included as a
patient variable in the current study, the data demonstrated
that high levels of lesion detection were achievable in unsedated
patients and that adenoma detectionwas not reduced in patients
undergoing unsedated colonoscopy.
Two recent studies have analyzed patient and colonoscopy fac-
tors affecting ADR using multivariable analysis [36,37]. Jover et
al. analyzed 4539 colonoscopies in a Spanish trial of screening co-
lonoscopy compared with fecal immunochemical testing [36].
Their statistical approach and findings were similar to those de-
scribed in our paper; however, potential confounding patient fac-
tors were limited to age, sex, and hospital. Adler et al. analyzed
12134 screening colonoscopies in the Berlin Colonoscopy Project
[37]. Their statistical approach differed to ours in that their out-
come variable was ADR as a continuous variable. Their findings of
a positive association of age, sex, and bowel preparation quality
are consistent with our findings; however, they did not find an
associationwithwithdrawal time, probably explained by the nar-
rower range of mean withdrawal times (6–11 minutes).
Recent studies have drawn attention to the importance of detec-
tion of serrated polyps [38]. The current study did not include
serrated polyps alone as an outcome measure, although serrated
adenomas were included in the adenoma count when detected.
Recognition and categorization of serrated polyps has evolved
since the dataset was completed in 2009. A recent Dutch study
of 1354 patients and five colonoscopists found that increasing
withdrawal time was associated with increase in proximal serra-
ted polyp detection [39]. No other colonoscopic factors and no
patient factors were demonstrated to be associated with proxi-
mal serrated polyp detection, although the relatively small study
Table 4 Ordinal regression
model of the effect of patient and
colonoscopy factors on the total
number of adenomas detected
per procedure.
OR 95%CI P
Sex
Male 1.89 1.78–1.99 < 0.001
Female 1.00 – –
Age, years
< 62.5 0.75 0.70–0.80 < 0.001
62.5–64.9 0.82 0.76–0.88 < 0.001
65–67.49 0.90 0.84–0.96 0.003
≥67.5 1.00 – –
Smoking
Never 0.55 0.51–0.60 < 0.001
Ex-smoker 0.64 0.59–0.70 < 0.001
Current smoker 1.00 – –
Alcohol
No 0.76 0.72–0.81 < 0.001
Yes 1.00 – –
Cecal Intubation
No 0.24 0.19–0.27 < 0.001
Yes 1.00 – –
Rectal retroversion
No 1.34 0.82–0.68 < 0.001
Yes 1.00 – –
Mean nc-CWT, minutes
< 10 0.89 0.84–0.93 < 0.001
≥10 1.00 – –
Bowel preparation quality
Inadequate preparation 0.70 0.63 –0.79 < 0.001
Excellent or adequate 1.00 –
Hyoscine use
No 0.76 0.73–0.80 < 0.001
Yes 1.00 – –
Start time of procedure
08:00–11.00 or 14:00–16:00 1.08 1.03–1.13 0.003
11:00–14:00 or 16:00–18:00 1.00 – –
Prior colonoscopist experience in the BCSP,
number of procedures
0–299 0.81 0.75–0.88 < 0.001
≥300 1.00 – –
Variables with a P value<0.1 in univariable analysis were not included.
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may have been underpowered to demonstrate other relation-
ships.
The current study has a number of limitations. First, data were
not available on some notable patient risk factors including fam-
ily history of CRC and aspirin use. Secondly, this study is retro-
spective in design and lacks the advantages of a prospective ran-
domized controlled trial. However, the size and breadth of the
dataset offset some of these limitations. Thirdly, the indication
for all colonoscopies in the study was a positive FOBT. This poten-
tially affects the external validity of the findings outside the con-
text of an FOBT-positive population where the yield of adenomas
is considerably higher than in those undergoing primary screen-
ing colonoscopy or in the general average-risk population.
A number of the colonoscopy factors included in the current
study have also been demonstrated to be associated with adeno-
ma detection in nonscreening populations [40]. It is likely that
many of the findings of the current study would also apply to
adenoma detection in the general population undergoing colo-
noscopy. The clinical objective of colonoscopy outside of a screen-
ing program, however, may not be cancer or adenoma detection.
In summary, this large study has demonstrated the importance of
technical colonoscopy factors in determining adenoma detection
during colonoscopy. The study identified colonoscopist-modifi-
able factors (cecal intubation, mean withdrawal time, bowel
preparation quality, use of intravenous antispasmodic, and start
time of the colonoscopy) that can help to optimize adenoma de-
tection and improve the quality of colonoscopy. These factors af-
fect not only the risk of detecting one or more adenomas but also
advanced adenomas, right-sided adenomas, and total number of
adenomas.
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